Skip to main content
Abliva logo

Abliva — Investor Relations & Filings

Ticker · ABLI ISIN · SE0002575340 LEI · 5493005YV22OTMUHZ183 ST Manufacturing
Open in API
Filings indexed 594 across all filing types
Latest filing 2024-04-30 Declaration of Voting R…
Country SE Sweden
Listing ST ABLI

About Abliva

https://abliva.com

Abliva is a biopharmaceutical company that discovers and develops medicines for the treatment of primary mitochondrial diseases. These are rare, congenital, and often severe genetic disorders that occur when the cell's energy converters, the mitochondria, are dysfunctional. The company's research and development is focused on creating novel therapies aimed at restoring mitochondrial function and addressing the significant unmet medical needs of patients. Abliva's primary goal is to deliver treatments that provide meaningful clinical benefits for individuals suffering from these debilitating conditions.

Recent filings

Filing Released Lang Actions
Ändring av antal aktier och röster i Abliva AB (publ)
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a short announcement from Abliva AB regarding a change in the total number of shares and votes following a rights issue ('företrädesemission'). It explicitly states the new total count and the date this information is effective. This type of announcement, which details changes in the capital structure (specifically the number of shares outstanding), aligns best with the 'Share Issue/Capital Change' category (SHA). Although it is a regulatory announcement, SHA is more specific than the general RNS fallback. The document is short and serves as a direct notification of a capital event, not a comprehensive report.
2024-04-30 Swedish
Amended number of shares and votes in Abliva AB (publ)
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly announces an 'Amended number of shares and votes' following a preferential rights issue, stating the total number of shares and votes as of the last trading day of the month (April 30, 2024). This directly relates to a change in the company's capital structure or share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (Code: SHA). Although it is a short announcement, the core content is the capital change itself, not just the announcement of a separate report, making SHA a better fit than RPA or RNS. The text mentions the obligation to make the information public, typical of regulatory disclosures regarding share capital.
2024-04-30 English
Abliva beslutar om en riktad emission av aktier till garanter i samband med den genomförda företrädesemissionen
Capital/Financing Update Classification · 1% confidence The document is a press release from Abliva AB dated April 25, 2024, announcing a directed share issue (Ersättningsemissionen) to guarantors who provided commitments for a previous rights issue (Företrädesemissionen). This action involves the issuance of new shares to settle guarantee fees, which directly impacts the company's capital structure and share count. This falls under the category of financing activities or capital structure changes. The most appropriate classification among the provided options is 'Capital/Financing Update' (CAP). It is not a full Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV). Since it is a specific announcement about a share issuance related to financing/guarantees, CAP is the best fit.
2024-04-25 Swedish
Abliva resolves on a directed issue of shares to guarantors in connection with the completed rights issue
Capital/Financing Update Classification · 1% confidence The document is a press release dated April 25, 2024, announcing that Abliva AB has resolved on a directed issue of shares to guarantors as compensation for commitments made during a prior rights issue. This action involves the issuance of new shares and a change in the capital structure to settle a debt/obligation. This directly relates to fundraising, financing activities, or capital structure changes. Therefore, the most appropriate classification is 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it describes a specific corporate finance action.
2024-04-25 English
Annual Report (ESEF) 2023
Annual Report (ESEF) Classification · 1% confidence FY 2023
2024-04-24 Swedish
Kallelse till årsstämma i Abliva AB (publ)
AGM Information Classification · 1% confidence The document is titled "Kallelse till årsstämma i Abliva AB (publ)" which translates to "Notice of Annual General Meeting in Abliva AB (publ)". It details the date, time, location, registration procedures, agenda items (including election of board members, approval of financial statements, and remuneration guidelines), and proposals for shareholder votes. This content is characteristic of a formal notice calling shareholders to an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R (AGM Information). The document is a full notice, not just an announcement of a report, and it is highly specific to the AGM process.
2024-04-22 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.